Schering - PDFSEARCH.IO - Document Search Engine

Schering
Results: 483

#	Item
91	November 2013 PBAC Meeting Outcomes – Positive Recommendations November 2013 PBAC Meeting Outcomes – Positive Recommendations Drug and Form Drug use and type Listing requested by sponsor PBAC Recommendation ALOGLIPTI Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 17:21:09 Anti-diabetic drugs Merck Schering-Plough Organofluorides Statins Quality use of medicines Metformin Bevacizumab Sitagliptin/metformin Chemistry Organic chemistry Medicine
92	Microsoft Word - 8993857_1.docx Add to Reading List Source URL: patentdocs.typepad.com Language: English - Date: 2015-03-30 01:52:33 Mometasone furoate Organochlorides Patent law Pharmacology Clinical research Merck & Co. United States patent law Patent infringement Prior art Schering-Plough Glucocorticoids Pharmaceutical sciences
93	Schering-Plough Powerpoint presentation example Add to Reading List Source URL: www.asmi.com.au Language: English - Date: 2008-11-25 18:39:43 Brand equity Pharmaceuticals policy Drugs Marketing Medicinal chemistry Pharmacy
94	Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD, Duke Clinical Research Instit Add to Reading List Source URL: www.mesoblast.com Language: English* - Date: 2013-12-30 22:55:11 Infliximab Schering-Plough Pharmacology Medicine Monoclonal antibodies Centocor Immunosuppressants
95 $BASF / Wenzhou / Schering-Plough / Provinces of the People\'s Republic of China / Changzhou / Jintan$	Addendum List of Approved Active Constituents - APVMA Gazette 2, 4 February 2003 Add to Reading List Source URL: archive.apvma.gov.au Language: English - Date: 2014-06-30 19:46:13 BASF Wenzhou Schering-Plough Provinces of the People\'s Republic of China Changzhou Jintan
96	Date of Approval: December 15, 2014 FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA[removed] Add to Reading List Source URL: www.fda.gov Language: English Health Tylosin Monensin Center for Veterinary Medicine Beef Eimeria Fusobacterium necrophorum Schering-Plough Ionophore Medicine Antibiotics Biology
97	DRUG, SPONSOR, TYPE OF SUBMISSION DRUG TYPE OR USE PURPOSE OF REVIEW PBAC OUTCOME EZETIMIBE + SIMVASTATIN ezetimibe 10 mg + simvastatin 10 mg tablet, 30 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 17:21:09 Organic chemistry Medicine Ezetimibe Simvastatin Statin Merck & Co. MG Cars Hypercholesterolemia Merck Schering-Plough Chemistry
98	Date of Approval: January 30, 2015 FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA[removed] Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Pharmaceutical industry Aminoglycoside antibiotics Food and Drug Administration Clinical research Bioequivalence Schering-Plough Generic drug Gentamicin Pharmacology Medicine Pharmaceuticals policy
99	Temozolomide Chemotherapy Information: Temozolomide Medication information leaflet for Add to Reading List Source URL: www.pics.org.au Language: English - Date: 2011-05-15 22:24:45 Prodrugs Schering-Plough Temozolomide Pharmacist Pharmacy Chemotherapy Medicine Amides Lactams
100	Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD, Duke Clinical Research Instit Add to Reading List Source URL: mesoblast.com Language: English* - Date: 2013-12-30 22:55:11 Infliximab Schering-Plough Pharmacology Medicine Monoclonal antibodies Centocor Immunosuppressants

UPDATE